AllianceBernstein’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,723
| Closed | -$71.8K | – | 3245 |
|
|
2025
Q1 | $71.8K | Hold |
14,723
| – | – | ﹤0.01% | 3096 |
|
|
2024
Q4 | $123K | Sell |
14,723
-4
| -0% | -$35 | ﹤0.01% | 3105 |
|
|
2024
Q3 | $153K | Hold |
14,727
| – | – | ﹤0.01% | 3074 |
|
|
2024
Q2 | $290K | Buy |
14,727
+6,277
| +74% | +$126K | ﹤0.01% | 2922 |
|
|
2024
Q1 | $216K | Hold |
8,450
| – | – | ﹤0.01% | 2913 |
|
|
2023
Q4 | $233K | Buy |
8,450
+568
| +7% | +$34.6K | ﹤0.01% | 2937 |
|
|
2023
Q3 | $479K | Hold |
7,882
| – | – | ﹤0.01% | 2595 |
|
|
2023
Q2 | $519K | Buy |
7,882
+2,941
| +60% | +$215K | ﹤0.01% | 2622 |
|
|
2023
Q1 | $314K | Sell |
4,941
-78
| -2% | -$8.91K | ﹤0.01% | 2756 |
|
|
2022
Q4 | $695K | Sell |
5,019
-1,040
| -17% | -$147K | ﹤0.01% | 2469 |
|
|
2022
Q3 | $767K | Sell |
6,059
-392
| -6% | -$44.4K | ﹤0.01% | 2429 |
|
|
2022
Q2 | $534K | Buy |
6,451
+3,834
| +147% | +$297K | ﹤0.01% | 2654 |
|
|
2022
Q1 | $254K | Sell |
2,617
-635
| -20% | -$83.8K | ﹤0.01% | 2927 |
|
|
2021
Q4 | $650K | Sell |
3,252
-3,250
| -50% | -$767K | ﹤0.01% | 2630 |
|
|
2021
Q3 | $1.61M | Hold |
6,502
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q2 | $2.69M | Buy |
6,502
+4,784
| +278% | +$1.9M | ﹤0.01% | 2006 |
|
|
2021
Q1 | $671K | Sell |
1,718
-786
| -31% | -$387K | ﹤0.01% | 2561 |
|
|
2020
Q4 | $1.4M | Sell |
2,504
-3,918
| -61% | -$2.48M | ﹤0.01% | 2161 |
|
|
2020
Q3 | $4.49M | Buy |
6,422
+3,960
| +161% | +$3.09M | ﹤0.01% | 1386 |
|
|
2020
Q2 | $1.95M | Sell |
2,462
-3,300
| -57% | -$2.49M | ﹤0.01% | 1860 |
|
|
2020
Q1 | $3.43M | Buy |
5,762
+1,590
| +38% | +$1.55M | ﹤0.01% | 1362 |
|
|
2019
Q4 | $4.74M | Buy |
4,172
+2,162
| +108% | +$2.35M | ﹤0.01% | 1456 |
|
|
2019
Q3 | $2.39M | Sell |
2,010
-1,351
| -40% | -$2.06M | ﹤0.01% | 1819 |
|
|
2019
Q2 | $5.54M | Buy |
3,361
+727
| +28% | +$1.26M | ﹤0.01% | 1361 |
|
|
2019
Q1 | $5.37M | Buy |
2,634
+262
| +11% | +$461K | ﹤0.01% | 1346 |
|
|
2018
Q4 | $3.05M | Sell |
2,372
-21,731
| -90% | -$33.3M | ﹤0.01% | 1583 |
|
|
2018
Q3 | $45.6M | Sell |
24,103
-720
| -3% | -$1.49M | 0.03% | 555 |
|
|
2018
Q2 | $50.5M | Buy |
24,823
+2,882
| +13% | +$6.57M | 0.04% | 501 |
|
|
2018
Q1 | $48.5M | Buy |
21,941
+14,810
| +208% | +$37.7M | 0.04% | 491 |
|
|
2017
Q4 | $16.5M | Buy |
7,131
+1,001
| +16% | +$2.03M | 0.01% | 833 |
|
|
2017
Q3 | $10.9M | Sell |
6,130
-361
| -6% | -$504K | 0.01% | 921 |
|
|
2017
Q2 | $8.83M | Sell |
6,491
-137
| -2% | -$165K | 0.01% | 969 |
|
|
2017
Q1 | $7.8M | Buy |
6,628
+2,211
| +50% | +$2.26M | 0.01% | 1002 |
|
|
2016
Q4 | $3.53M | Buy |
4,417
+77
| +2% | +$61.1K | ﹤0.01% | 1416 |
|
|
2016
Q3 | $3.81M | Sell |
4,340
-54
| -1% | -$39.1K | ﹤0.01% | 1288 |
|
|
2016
Q2 | $2.46M | Buy |
4,394
+2,886
| +191% | +$1.63M | ﹤0.01% | 1527 |
|
|
2016
Q1 | $830K | Buy |
1,508
+16
| +1% | +$9.83K | ﹤0.01% | 2201 |
|
|
2015
Q4 | $1.24M | Sell |
1,492
-15
| -1% | -$15K | ﹤0.01% | 1993 |
|
|
2015
Q3 | $1.67M | Buy |
1,507
+40
| +3% | +$72.9K | ﹤0.01% | 1794 |
|
|
2015
Q2 | $3.2M | Sell |
1,467
-1,546
| -51% | -$3.15M | ﹤0.01% | 1400 |
|
|
2015
Q1 | $4.71M | Buy |
3,013
+296
| +11% | +$391K | ﹤0.01% | 1149 |
|
|
2014
Q4 | $3.23M | Buy |
2,717
+424
| +18% | +$283K | ﹤0.01% | 1391 |
|
|
2014
Q3 | $1.07M | Buy |
2,293
+54
| +2% | +$24.9K | ﹤0.01% | 2153 |
|
|
2014
Q2 | $1.12M | Buy |
2,239
+2,235
| +55,875% | +$716K | ﹤0.01% | 2178 |
|
|
2014
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 3516 |
|
|
2013
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 3318 |
|
|
2013
Q3 | $2K | Buy |
+4
| New | +$1.49K | ﹤0.01% | 3227 |
|
Other funds holding BLUE
AllianceBernstein's BLUE Position: Q2 2025 in Review
AllianceBernstein sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 14,723 shares — an estimated $71.8K sold.
AllianceBernstein first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $50.5M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- AllianceBernstein reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- AllianceBernstein sold 14,723 bluebird bio shares in Q2 2025, an estimated $71.8K.
- AllianceBernstein first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- AllianceBernstein's bluebird bio position peaked at $50.5M in Q2 2018.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.